Health and Fitness Health and Fitness
Mon, July 2, 2012
[ Mon, Jul 02nd 2012 ] - Market Wire
Avanir Pharmaceuticals Announces Notice Of Allowance Of U.S. Patent Application Covering NUEDEXTA
[ Mon, Jul 02nd 2012 ] - Market Wire
Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device
[ Mon, Jul 02nd 2012 ] - Market Wire
USANA Health Sciences Names Dr. Carsten Smidt As Its Vice President Of Research And Development
[ Mon, Jul 02nd 2012 ] - Market Wire
Equity Research on Perrigo Co. and Auxilium Pharm .. - Drug Related Products Developing and Expanding
[ Mon, Jul 02nd 2012 ] - Market Wire
Onyx Pharmaceuticals Initiates Phase 3 Kyprolisa" .. al vs. Velcade in Patients with Relapsed Multiple
[ Mon, Jul 02nd 2012 ] - Market Wire
Amerigroup Now Serving Members in Washington State
[ Mon, Jul 02nd 2012 ] - Market Wire
Cold-EEZE Announces Launch of NEW Cold-EEZE Cold .. kMelts and achieves Nationwide Product Distributi
[ Mon, Jul 02nd 2012 ] - Market Wire
Cytomedix Announces Extension of Exclusivity Peri .. ompany for Autologel System in Chronic Wound Mark
[ Mon, Jul 02nd 2012 ] - Market Wire
NuPathe Updates Migraine Patch NDA Resubmission Timing
[ Mon, Jul 02nd 2012 ] - Market Wire
The Medicines Company Expects Cangrelor Phase 3 Trial Enrollment Completion in 2012
[ Mon, Jul 02nd 2012 ] - Market Wire
Corcept Therapeutics Commences Public Offering of Common Stock
Sun, July 1, 2012
[ Sun, Jul 01st 2012 ] - Market Wire
New data published on RUCONEST's protective effects after severe blood loss
Fri, June 29, 2012
[ Fri, Jun 29th 2012 ] - Market Wire
Saxena White P.A. Files Securities Fraud Class Action Against Centene Corporation
[ Fri, Jun 29th 2012 ] - Market Wire
Cascade Technologies Appoints Dr. Jerome Swartz t .. ; Highly Accomplished Technology Executive Br
[ Fri, Jun 29th 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. xcess of $100,000 from Investing in MAKO Surgical
[ Fri, Jun 29th 2012 ] - Market Wire
Faruqi & Faruqi, LLP Encourages Investors Who Suf .. 0,000 from Investing in MAKO Surgical Corporation
[ Fri, Jun 29th 2012 ] - Market Wire
Amerigroup Corporation to Discuss Second Quarter Earnings on August 1
[ Fri, Jun 29th 2012 ] - Market Wire
Digirad and Red Oak Partners Agree to Further Str .. Digirad's Commitment to Governance Best Practices
[ Fri, Jun 29th 2012 ] - Market Wire
Assisted Living Concepts, Inc. Announces Conference Call
[ Fri, Jun 29th 2012 ] - Market Wire
Centene Schedules 2012 Second Quarter Financial Results Conference Call
[ Fri, Jun 29th 2012 ] - Market Wire
Hospira to Host Conference Call for Second-quarter 2012 Results
[ Fri, Jun 29th 2012 ] - Market Wire
Trimel Pharmaceuticals Corporation Announces Terms of $13.25 Million Equity Financing
[ Fri, Jun 29th 2012 ] - Market Wire
Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
[ Fri, Jun 29th 2012 ] - Market Wire
Ohr Pharmaceutical Announces $2.9 Million Financing
[ Fri, Jun 29th 2012 ] - Market Wire
SpectraScience Begins Shipments of WavSTAT4 Optical Biopsy System to PENTAX in Europe
[ Fri, Jun 29th 2012 ] - Market Wire
Sirona Biochem Releases Quarterly Financial Results
[ Fri, Jun 29th 2012 ] - Market Wire
Hamilton Thorne Showcases Two New Products for Fertility Clinics at ESHRE 2012
[ Fri, Jun 29th 2012 ] - Market Wire
Daxor Corporation Announces Filing of Form N-2 an .. ments for the Daxor BVA-100 Blood Volume Analyzer
[ Fri, Jun 29th 2012 ] - Market Wire
Equity Research on St. Jude Medical Inc. and Zimm .. pliances and Equipment Companies Facing Legal Bat
[ Fri, Jun 29th 2012 ] - Market Wire
Horizon Pharma to Present at the 7th Annual JMP Securities Healthcare Conference

Horizon Pharma to Present at the 7th Annual JMP Securities Healthcare Conference


Published on 2012-06-29 04:38:35 - Market Wire
  Print publication without navigation


June 29, 2012 07:30 ET

Horizon Pharma to Present at the 7th Annual JMP Securities Healthcare Conference

DEERFIELD, IL--(Marketwire - Jun 29, 2012) -  Horizon Pharma, Inc. (NASDAQ: [ HZNP ]) today announced that Todd N. Smith, Executive Vice President and Chief Commercial Officer, will present at the JMP Securities Healthcare Conference on Thursday, July 12, 2012 at 12:00 p.m. Eastern Time in New York, NY. Mr. Smith will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at [ http://ir.horizon-pharma.com ]. A replay of the webcast will be available for 10 business days.

About Horizon Pharma
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit [ www.horizonpharma.com ].


Contributing Sources